Structured evidence table for Resveratrol Inflammation Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Inflammation Meta-Analysis | Obesity, defined as excessive accumulation of adipose tissue, is strongly associated with metabolic complications, including hypertension, dyslipidemia, and type 2 diabetes [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Inflammation Meta-Analysis | Chronic low-grade inflammation associated with obesity contributes to metabolic dysfunction through the increased production of pro-inflammatory cytokines and adipocytokines []. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Inflammation Meta-Analysis | 5 6 7 8 9 10 11 Studies show that obesity significantly increases the risk of chronic diseases, including type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, hyperuricemia, and insulin resistance [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Inflammation Meta-Analysis | 1 2 3 4 Metabolic disorders pose a serious challenge to healthcare systems worldwide due to their significant impact on quality of life, requiring a holistic approach in the context of prevention, diagnosis, and treatment. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Inflammation Meta-Analysis | The aim of this systematic review was to synthesize available evidence regarding the metabolic and pancreatic effects of resveratrol in diabetes mellitus. | 1 | Meden A (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine-endocrine pancreatic axis-a systematic review. |
| Resveratrol Inflammation Meta-Analysis | Evidence from experimental and clinical studies indicates that resveratrol may improve glycemic control, attenuate inflammatory responses, reduce oxidative stress, and protect pancreatic β-cell function, primarily through activation of signaling pathways such as sirtuin-1 (SIRT1) and AMP-activated protein kinase (AMPK). | 1 | Meden A (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine-endocrine pancreatic axis-a systematic review. |
| Resveratrol Inflammation Meta-Analysis | Most available evidence originates from studies in type 2 diabetes mellitus or experimental models of diabetes. | 1 | Meden A (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine-endocrine pancreatic axis-a systematic review. |
| Resveratrol Inflammation Meta-Analysis | Pancreatic dysfunction plays an important role in the development and progression of diabetes mellitus. | 1 | Meden A (2026) | Resveratrol in diabetes and pancreatic function: implications for the exocrine-endocrine pancreatic axis-a systematic review. |
Source documents